Tempest TherapeuticsTPST
13F holders, Q2 2025 (June 30)17holders +15
3new positions
2sold out
$6.80avg. 13F price*
At the end of Q2 2025, 17 institutions reported holding Tempest Therapeutics Inc. (TPST) in their 13F filings, up 15 from Q1 2025. 3 opened new positions and 2 sold out. The largest holders were Sabby Management, LLC ($1.9M), Tang Capital Management LLC ($945K) and Vanguard Group Inc. ($915K).
- Company
- Tempest Therapeutics Inc.
- CUSIP
- 87978U207
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2025 → Q2 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 3 | $2.8M |
| Exits | 2 | $2.7M |
All 13F filers, Q1 2025 → Q2 2025: 529,229 shares bought and 3,535,752 shares sold, net −3,006,523 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 17 holders
| Sabby Management, LLC | 15.21% | New | 276,587 | $1.9M |
| Tang Capital Management LLC | 0.05% | New | 138,962 | $945K |
| Vanguard Group Inc. | 0.00% | Add +488.1% | 134,608 | $915K |
| BlackRock, Inc. | 0.00% | Reduce -9.4% | 39,068 | $266K |
| Geode Capital Management, LLC | 0.00% | Add +4.3% | 34,736 | $236K |
| FMR LLC | 0.00% | Add +0.1% | 33,225 | $226K |
| UBS Group AG | 0.00% | Reduce -54.9% | 11,223 | $76K |
| Morgan Stanley | 0.00% | Reduce -38.3% | 2,107 | $14K |
| Osaic Holdings, Inc. | 0.00% | Reduce -7.2% | 1,834 | $12K |
| National Bank of Canada | 0.00% | No change | 1,538 | $10K |
| Federation des caisses Desjardins du Quebec | 0.00% | No change | 292 | $2K |
| CIBC Private Wealth Group LLC | 0.00% | Add +2444.0% | 260 | $2K |
| Raymond James Financial Inc. | 0.00% | New | 234 | $2K |
| SBI Securities Co., Ltd. | 0.00% | Reduce -92.7% | 56 | $381 |
| Bank of America Corp. | 0.00% | Add +23.1% | 33 | $225 |
| Parallel Advisors, LLC | 0.00% | Reduce -0.7% | 18 | $122 |
| BNP Paribas Financial Markets | 0.00% | Reduce -18.7% | 3 | $20 |
"% of holder's portfolio" is TPST's weight in each manager's 13F, not the share of Tempest Therapeutics Inc. the manager owns.